OPDEXQI Trademark

Trademark Overview


On Thursday, December 15, 2022, a trademark application was filed for OPDEXQI with the United States Patent and Trademark Office. The USPTO has given the OPDEXQI trademark a serial number of 97719899. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Glaxo Group Limited. The OPDEXQI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, hepatological, neurological, psychiatric and immune system related diseases and disorders
opdexqi

General Information


Serial Number97719899
Word MarkOPDEXQI
Filing DateThursday, December 15, 2022
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7275814
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, hepatological, neurological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateThursday, January 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 28, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 22, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 18, 2023ASSIGNED TO EXAMINER
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 16, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 16, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 19, 2022NEW APPLICATION ENTERED